Differentiating vasculitis from other diseases: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 23: | Line 23: | ||
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings | ! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings | ||
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | ! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | ||
! rowspan="2" |Histopathology | ! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | ||
|- | |- | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | ||
Line 150: | Line 150: | ||
|- | |- | ||
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Fibromuscular dysplasia]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Fibromuscular dysplasia]]<ref name="pmid17555581">{{cite journal| author=Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X| title=Fibromuscular dysplasia. | journal=Orphanet J Rare Dis | year= 2007 | volume= 2 | issue= | pages= 28 | pmid=17555581 | doi=10.1186/1750-1172-2-28 | pmc=1899482 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17555581 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 163: | Line 163: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ [[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ [[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Alternating [[stenosis]] and [[Dilatation|dilatations]] in [[CT angiography]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stenosis]] in the [[renal arteries]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Luminal narrowing alternating with [[dilatation]] (Beads sign) | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Focal [[concentric]], long-segment [[tubular]] [[stenosis]] or outpouching in [[MRA]] | ||
! | !Fibrodysplastic changes, [[Collagen]] deposition | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Digital subtraction angiography|Digital subtraction angiography (DSA)]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Spontaneous coronary artery dissection|Spontaneous coronary artery dissection (SCAD)]] | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Spontaneous coronary artery dissection|Spontaneous coronary artery dissection (SCAD)]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Ehlers-Danlos syndrome]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Ehlers-Danlos syndrome]]<ref name="pmid27824552">{{cite journal| author=Gazit Y, Jacob G, Grahame R| title=Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder. | journal=Rambam Maimonides Med J | year= 2016 | volume= 7 | issue= 4 | pages= | pmid=27824552 | doi=10.5041/RMMJ.10261 | pmc=5101008 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27824552 }}</ref> | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[TGF-β]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Cultured skin [[fibroblasts]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Multiple [[vascular]] segments with [[aneurysms]] and [[dissections]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Dissection]] of the [[Circumflex branch of left coronary artery|posterolateral branch of the left circumflex coronary artery (LCx)]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Visceral]] [[arteries]] abnormality | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Vascular anomaly|Vascular abnormalities]] in [[MRA]] | ||
! | !Thin and rare [[collagen]] bundles in the [[dermis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |History and [[physical examination]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bleeding]], [[Easy bruising|Bruisability]], [[Heart murmur]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polymyalgia rheumatica|Polymyalgia rheumatica (PMR)]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polymyalgia rheumatica|Polymyalgia rheumatica (PMR)]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 211: | Line 211: | ||
! | ! | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Joint stiffness]], [[Fatigue]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Amyloidosis]] | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Amyloidosis]] | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 233: | Line 233: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |||
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Arthralgia | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Claudication | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Bruit | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |HTN | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Focal neurological disorder | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Biomarker | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CBC | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard''' | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | |||
|- | |- | ||
! rowspan="18" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Medium-Vessel Vasculitis | ! rowspan="18" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Medium-Vessel Vasculitis | ||
Line 615: | Line 636: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |||
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Arthralgia | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Claudication | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Bruit | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |HTN | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Focal neurological disorder | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Biomarker | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CBC | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard''' | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | |||
|- | |- | ||
! rowspan="33" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Small-Vessel Vasculitis | ! rowspan="33" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Small-Vessel Vasculitis | ||
Line 1,317: | Line 1,359: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |||
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Arthralgia | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Claudication | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Bruit | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |HTN | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Focal neurological disorder | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Biomarker | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CBC | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard''' | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | |||
|- | |- | ||
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Variable-vessel vasculitis | ! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Variable-vessel vasculitis |
Revision as of 18:51, 27 March 2018
Vasculitis |
|
---|
gsEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Differential Diagnosis
Abbreviations: ABG= Arterial blood gas, ANP= Atrial natriuretic peptide, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure.
References
- ↑ Vaideeswar P, Deshpande JR (2013). "Pathology of Takayasu arteritis: A brief review". Ann Pediatr Cardiol. 6 (1): 52–8. doi:10.4103/0974-2069.107235. PMC 3634248. PMID 23626437.
- ↑ Calvo-Romero JM (2003). "Giant cell arteritis". Postgrad Med J. 79 (935): 511–5. PMC 1742823. PMID 13679546.
- ↑ Stafa A, Leonardi M (2008). "Role of neuroradiology in evaluating cerebral aneurysms". Interv Neuroradiol. 14 Suppl 1: 23–37. doi:10.1177/15910199080140S106. PMC 3328052. PMID 20557771.
- ↑ Cassiman C, Casteels I, Stalmans P, Legius E, Jacob J (2017). "Optical Coherence Tomography Angiography of Retinal Microvascular Changes Overlying Choroidal Nodules in Neurofibromatosis Type 1". Case Rep Ophthalmol. 8 (1): 214–220. doi:10.1159/000469702. PMC 5422752. PMID 28512424.
- ↑ Evans, D G. R (2000). "Neurofibromatosis type 2". Journal of Medical Genetics. 37 (12): 897–904. doi:10.1136/jmg.37.12.897. ISSN 1468-6244.
- ↑ Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X (2007). "Fibromuscular dysplasia". Orphanet J Rare Dis. 2: 28. doi:10.1186/1750-1172-2-28. PMC 1899482. PMID 17555581.
- ↑ Gazit Y, Jacob G, Grahame R (2016). "Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder". Rambam Maimonides Med J. 7 (4). doi:10.5041/RMMJ.10261. PMC 5101008. PMID 27824552.